--- title: 'Associate Director, HCP Marketing at BridgeBio Pharma' canonical: 'https://feeny.ai/job/associate-director-hcp-marketing-bridgebio-pharma-san-francisco-141ggr9213nb' type: 'job' last_seen: '2026-09-16' --- # Associate Director, HCP Marketing at BridgeBio Pharma - **Company:** BridgeBio Pharma - **Location:** San Francisco, CA - **Compensation:** $182k–$235k - **Posted:** 2026-09-11 - **Last confirmed live:** 2026-09-16 - **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5234783007 ## Job description Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. ## Who You Are The Associate Director, HCP Marketing will support the development and commercialization of key assets. The Associate Director, HCP Marketing will drive cross-functional collaboration and tactical alignment, ensuring success in the US. This individual will lead the development and execution of tactics supporting the commercial launch of BBP-418.  This person will occupy an important role on commercial product teams, work closely with Market Insights, Market Access, Regulatory, Medical Affairs, and other key stakeholders to deliver integrated commercial planning and execution.   The Associate Director, HCP Marketing, should feel at home in a fast-paced, ambiguous environment. This position requires excellent communication, organization and collaboration skills. The Associate Director, HCP Marketing will report to the Director of Marketing. ## What You'll Do ## Responsibilities - Serve as a commercial member on product teams, embedding the market needs into cross functional planning - Drive innovative tactics and address untapped opportunities - Lead brand planning, messaging and claims work - Lead agile, cross-functional team to develop/launch innovative marketing campaigns that will inspire behavioral change and drive brand growth; ensure aligned launch execution across functions - Develop and track metrics to measure and ensure the success of marketing/promotional programs - Lead commercial convention presence, including target meeting, booth design and production and overall commercial presence across channels - Partner with Market Access to help develop access/ reimbursement strategies - Partner closely with commercial and medical teams to develop tactics that will help identify doctors that have, or are most likely to have LGMD2I/R9 patients - Partner with regional teams to ensure diverse commercial insights are brought into the planning process, be the commercial voice advocating for these views - Manage and evolve the disease education campaign and educational resources - Develop and manage the speaker bureau, inclusive of program structure / development / maintenance, speaker selection, vendor leadership and innovative approaches to further brand messaging and positioning - Lead the creation of all HCP peer-to-peer educational content - Collaborate with the Digital team to support execution of launch and pre-launch activities - Proactively evaluate/assess the relevant market landscape, monitoring changes in market dynamics, competition, clinician needs and practices - Develop targeted measurement plans to help evaluate effectiveness of HCP tactics and prioritization of efforts - Work cross-functionally with agency partners, sales, commercial operations, brand analytics, IT, MCM, et Where You'll Work This is a hybrid role and requires in-office collaboration 3x per week in our San Francisco Office. ## Who You Are Education, Experience & Skills Requirements - 5+ years of commercial biotech or pharmaceutical experience, with at least three years in Marketing - Successful launch experience in a competitive market is preferred - Rare disease experience preferred - Demonstrated ability to develop and action insights from complex clinical data and market research - Understanding of the drug development process, especially regarding opportunities for differentiation and value demonstration - Excellent oral, written, and presentation skills - Passionate about serving patients suffering from Genetic diseases - Proven self-starter, able to work independently and as part of a team - Able to handle full workload across multiple projects - Collaborates seamlessly across functions to build effective working relationships and align strategy and execution. - High level of self-awareness and understanding of the importance of self-monitoring behavior for continuous improvement - Experience leading KOL engagement activities is a plus - True entrepreneurial spirit – BridgeBio was built to do things differently and address the needs of underserved populations, driven by science and unrelenting passion for patients - Ability to travel (~25%) is required ## #LI-LN1 At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states. Salary $181,500—$235,000 USD As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return. For BridgeBio Full-Time U.S Based Roles: Financial & Rewards - Market-leading compensation - 401(k) with employer match - Employee Stock Purchase Program (ESPP) - Pre-tax commuter benefits (transit and parking) - Referral bonus for hired candidates - Subsidized lunch and parking on in-office days Health & Well-Being - 100% employer-paid medical, dental, and vision premiums for you and your dependents - Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA) - Fertility & family-forming benefits - Expanded mental health support (therapy and coaching resources) - Hybrid work model with flexibility - Flexible, “take-what-you-need” paid time off and company-paid holidays - Comprehensive paid medical and parental leave to care for yourself and your family Skill Development & Career Paths: - People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility - We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching - We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities ## About BridgeBio Pharma ## Company Overview - **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization. - **Entity Type**: Public (Nasdaq: BBIO) - **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA) - **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016. - **Founders**: Not publicly available from provided sources. ## Core Business - **Primary industry**: Biotechnology / Genetic disease therapeutics - **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners - **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.” ## Products & Services BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings: - **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential. - **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026). - **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). - **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1). - **BBP-812**: Investigational for Canavan Disease. - **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers. - **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology. - **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more. The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**. ## Market Standing - **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number). - **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years. - **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research. - **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted. ## Competitive Advantages - **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction. - **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale. - **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech. - **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions. ## Strategic Focus - **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals. - **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers. - **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster. - **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach. ## Why Work Here - **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025. - **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized. - **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility. - **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra. - **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.” - **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles. ## Sources 1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential 2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics 3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits 4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation 5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories ## Other roles at BridgeBio Pharma - [Director, Regulatory CMC](https://feeny.ai/job/director-regulatory-cmc-bridgebio-pharma-united-states-ebrxcpgtzc77) — United States - [Sr. Director/ Exec. Director- CMC, Drug Product](https://feeny.ai/job/sr-director-exec-director-cmc-drug-product-bridgebio-pharma-san-francisco-q4qjnhbq8gr4) — San Francisco, CA - [Family Access Manager (FAM), Skeletal Dysplasia - SOUTH EAST](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-south-east-bridgebio-pharma-united-s8j14mgc07nz) — United States - [Family Access Manager (FAM), Skeletal Dysplasia - EAST](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-east-bridgebio-pharma-united-states-jy27te2gkqcf) — United States - [Family Access Manager (FAM), Skeletal Dysplasia - MID-ATLANTIC](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-mid-atlantic-bridgebio-pharma-prrt1cr049ev) — United States - [Family Access Manager (FAM), Skeletal Dysplasia - MIDWEST](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-midwest-bridgebio-pharma-united-7cm4g2xyrx8d) — United States - [Family Access Manager (FAM), Skeletal Dysplasia - South West](https://feeny.ai/job/family-access-manager-fam-skeletal-dysplasia-south-west-bridgebio-pharma-united-cnw8gmc9bmtp) — United States - [Family Access Manager (FAM), Skeletal Dyplasia - WEST](https://feeny.ai/job/family-access-manager-fam-skeletal-dyplasia-west-bridgebio-pharma-united-states-v27ht06awxjg) — United States - [Senior Manager, Computer System Validation QA](https://feeny.ai/job/senior-manager-computer-system-validation-qa-bridgebio-pharma-united-states-8gk11e5n2xrb) — United States - [Medical Director, Clinical Science](https://feeny.ai/job/medical-director-clinical-science-bridgebio-pharma-united-states-bnevf5whdv71) — United States